Ian Haydon is the first person to volunteer to get tested for the coronavirus vaccine on the 8th of April 2020.
Haydon was the first of 45 test subject that had volunteered for this action.
Ian is a 29 year old communication specialist at the University of Washington.
He last week he signed a 20 page documents stating that he was aware of the risks that might transpire from the trial.
Before he underwent the test he said that his parents are proud of him but his mother serves as the more worried of the two.
While several vaccines are in development, this was the first to be tested on a human subject.
The vaccine was developed by Moderna Therapeutics, a company whose technology has allowed what has been deemed the fastest start-up of a vaccine trial ever.
Haydon has a lot faith in Moderna Therapeutics saying, “I think their technology is amazing, and I am glad it is being tried. It could be an important platform not only for coronavirus but for many diseases. I think Moderna is really in the hot seat now. I think their decision to develop a coronavirus vaccine and try it out in humans in the midst of a pandemic is a remarkable thing for any company to do. They seem to be putting a lot on the line here, and I hope it works.”
In March, 45 people were asked to volunteer at a Kaiser Permanente facility in Seattle.
According to a 20-page consent form the volunteers are signing, they acknowledge that there could be risks and the vaccine isn’t likely to help them.
They also agree to undergo a series of blood draws in the coming months, to share their genetic information, and asked to avoid having children during the study.
In an interview with MIT technology review, Haydon affirms that the research institute asked him to use protection and recommended that the subjects be under birth control.
He suspects it’s because the vaccine can be passed down in DNA. This is what he said when asked about it.
“I have been wondering about that too. I have some theories. I was specifically asked to make a promise to use protection. I wonder if, this being a genetic vaccine, someone wanted to guard against the possibility of a new generation of mRNA-vaccine children being born.”
The communications specialist feels he is doing great service for the world. He considers himself lucky to be in the position and to be healthy enough to participate especially after being selected from such a large gene pool.